(Q24626302)

21 June 2017

title

Comment: compulsory licensing of patented pharmaceutical inventions: evaluating the options (English)

1 reference

21 June 2017

0 references

Jerome H Reichman

1

1 reference

21 June 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

21 June 2017

number of pages

17

1 reference

Journal of Law, Medicine, and Ethics

inferred from page(s)

published in

1 reference

21 June 2017

volume

37

1 reference

21 June 2017

issue

2

1 reference

21 June 2017

page(s)

247-263

1 reference

An economic justification for open access to essential medicine patents in developing countries

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00369.X

The price of innovation: new estimates of drug development costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00369.X

Patent buy-outs for global disease innovations for low- and middle-income countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00369.X

Developing nations and the compulsory license: maximizing access to essential medicines while minimizing investment side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00369.X

7 January 2021

Compulsory licensing in Canada and Thailand: comparing regimes to ensure legitimate use of the WTO rules

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00369.X

7 January 2021

AIDS drugs. Brazil, Thailand override big pharma patents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00369.X

7 January 2021

Should access to medicines and TRIPS flexibilities be limited to specific diseases?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00369.X

7 January 2021

Right idea, wrong result--Canada's access to medicines regime

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00369.X

7 January 2021

Addressing supply side barriers to introduction of new vaccines to the developing world

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00369.X

7 January 2021

Market-based licensing for HPV vaccines in developing countries

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00369.X

7 January 2021

10.1111/J.1748-720X.2009.00369.X

Identifiers

DOI

1 reference

OpenCitations bibliographic resource ID

21 June 2017

4707836

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4707836

1 reference